Teva Adds To Biosimilars Capabilities Through Partnership With Lonza

Israeli generic giant, Swiss CMO announce joint venture to co-develop, manufacture and market biosimilars.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet